http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211351-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85046f5547cb42547fbf9569b15070cc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-206 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate | 2021-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82048c8d95f6d1dc6c4433bdf1a69088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65aec33888594a0f7db49d4fdab3aeed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd293fd68a45053c9a8fa3a422ad561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28960ab02fcf543c27746f345c00f08d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e95eb2796da3e0ccba0d92a26b1f1c7 |
| publicationDate | 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021211351-A1 |
| titleOfInvention | Devices and methods for treating a coronavirus infection and symptoms thereof |
| abstract | The devices and methods of the present invention can be used to capture and remove COVID-19 mediating nanoparticles and/or exosomes associated with COVID-19 or similar disease from the circulatory system of patients in need thereof, including those with post- COVID- 19 syndrome or similar post-disease sequelae so-called "long haul" symptoms of COVID-19 or similar disease. The present invention benefits patients by providing lectin based extracorporeal methods for binding and physically removing SA RS-C7oV-2 virions, or fragments thereof, from the circulatory system. Also provided are lectin based extracorporeal methods of binding and physically removing non-viral COVID-19 mediating nanoparticles. Also disclosed herein are devices and methods for reducing the levels of biomarkers and markers of morbidity/mortality of diseases such as COVID-19 and similar diseases, including cytokines, such as IL- 6, Troponin T, and D- dimer. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022169842-A1 |
| priorityDate | 2020-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.